AI assistant
Sending…
Hoth Therapeutics, Inc. — Director's Dealing 2019
Feb 15, 2019
34935_dirs_2019-02-15_e527f50d-09c3-4236-8544-1a5805a0471d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2019-02-14
Reporting Person: Hayes Anthony (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 105000 | Direct |
| Common Stock | 1700000 | Indirect |
Footnotes
F1: The securities are owned by Spherix Incorporated ("Spherix"). Anthony Hayes is the Chief Executive Officer and a member of the board of directors of Spherix and in such capacities has voting and dispositive power of the securities held by such entity.
More from Hoth Therapeutics, Inc.
Board/Management Information
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Regulatory Filings
2026
Jun 2
Capital/Financing Update
2026
May 28
Share Issue/Capital Change
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 6